We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BVS market cap is 314.29M. The company's latest EPS is USD -1.9735 and P/E is -2.02.
Quarter End | Oct 2022 | Dec 2022 | Apr 2023 | Jul 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 128.66M | 125.83M | 119.06M | 137.07M | 120.79M |
Operating Income | -198.72M | -29.12M | -91.77M | 87.13M | -74.89M |
Net Income | -108.25M | -31.93M | -139.15M | -3.68M | -7.3M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 340.14M | 321.16M | 430.9M | 512.12M | 512.35M |
Operating Income | 31.19M | 21.24M | 17.74M | -251.05M | -77.43M |
Net Income | 6.85M | 16.41M | 19.38M | -158.7M | -156.23M |
Quarter End | Oct 2022 | Dec 2022 | Apr 2023 | Jul 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 1.4B | 1.37B | 887.4M | 836.96M | 811.1M |
Total Liabilities | 1.02B | 1.03B | 647.04M | 603.62M | 584.65M |
Total Equity | 379.15M | 340.33M | 240.36M | 233.34M | 226.46M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 472.41M | 494.47M | 1.23B | 1.37B | 810.91M |
Total Liabilities | 326.79M | 350.31M | 692.07M | 1.03B | 589.79M |
Total Equity | 145.62M | 144.16M | 533.79M | 340.33M | 221.12M |
Quarter End | Oct 2022 | Dec 2022 | Apr 2023 | Jul 2023 | Sep 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -18.78M | -13.54M | 2.49M | 13.29M | 4.97M |
Investing | -113.03M | -116.44M | -15.07M | 18.43M | 16.4M |
Financing | 67.51M | 62.08M | 27.38M | -34.87M | -26.64M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | 40.71M | 71.8M | 22.99M | -13.54M | 15.34M |
Investing | -7.91M | -20.5M | -283.76M | -116.44M | 15.81M |
Financing | -11.06M | -29.57M | 273.37M | 62.08M | -26.65M |
Market Cap | 314.29M |
Price to Earnings Ratio | -2.02 |
Price to Sales Ratio | 0.61 |
Price to Cash Ratio | 8.52 |
Price to Book Ratio | 1.42 |
Dividend Yield | - |
Shares Outstanding | 79.17M |
Average Volume (1 week) | 108.96k |
Average Volume (1 Month) | 123.13k |
52 Week Change | 301.01% |
52 Week High | 6.08 |
52 Week Low | 0.86 |
Spread (Intraday) | 1.9 (33.33%) |
Company Name | Bioventus Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.bioventus.com |
Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions